XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.87% | -3.58% | -109.53% | 61.44% | -30.03% |
| Total Depreciation and Amortization | -0.68% | 0.68% | 0.00% | 0.92% | 0.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -197.67% | -35.60% | 1,482.46% | -136.66% | -52.47% |
| Change in Net Operating Assets | -350.81% | 156.46% | -29.34% | -453.82% | -35.31% |
| Cash from Operations | 10.88% | -2.75% | -11.89% | 48.62% | -57.96% |
| Capital Expenditure | 45.74% | -11.90% | 75.15% | 46.09% | -145.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 45.74% | -11.90% | 75.15% | 46.09% | -145.88% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -48.44% | 33.33% | -12.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -3,721.91% | 342.19% | 33.33% | -99.52% |
| Foreign Exchange rate Adjustments | 984.86% | 106.93% | -679.92% | 227.62% | 64.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.37% | -60.71% | -92.92% | 56.74% | -1,331.20% |